NEWSROOM
ChemLifeIntel Newsroom
The latest decision-grade intelligence across the global chemical and life sciences value chain — published daily, every brief carrying a named analyst byline and built from public-record sources.
900+
Briefs published
Daily
Publication cadence
8,000+
Entities covered
Named
Analyst bylines
Latest intelligence
Open the ExplorerCDSCO Enacts Sweeping Regulatory Changes Across India's Pharma and Medical Device Sectors
Meera Krishnan · 3h ago
ANSM Fines Novo Nordisk and Eli Lilly for GLP-1 Obesity Campaign Breaches, Novo Nordisk Explores Legal Challenge
Catherine Morrow · 4h ago
Kardigan's $400M IPO Fuels Cardiovascular Drug Development Amid Biotech Funding Surge
Catherine Morrow · 4h ago
Spero Therapeutics and GSK Secure FDA Approval for Oral cUTI Treatment Utebzi After Four-Year Regulatory Journey
Priya Subramaniam · 9h ago
GSK Elevates Exdensur with Direct-to-Consumer Campaign, Signaling Blockbuster Ambitions in Asthma Market
Meera Krishnan · 9h ago
Verastem Oncology Reprioritizes R&D, Shifting Focus from Avutometinib and Defactinib Combo in Pancreatic Cancer
Arjun Sharma · 9h ago
Boston University's SLATE Study Completes, Signaling Shift in Global HIV Antiretroviral Therapy Initiation Protocols
Meera Krishnan · 11h ago
FDA Faces Pressure to Restrict Livestock Antibiotic Use: Major Commercial Implications for Chemical and Life Sciences
Catherine Morrow · 13h ago
Cairo University Completes Clinical Study NCT06069635 on Fatigue and Performance in Adolescent Football Players
Catherine Morrow · 13h ago
J&J's MonumenTAL-3 Phase 3 Data for Talvey and Darzalex Faspro Signals Major Shift in Earlier Multiple Myeloma Treatment
Lakshmi Venkataraman · 13h ago
Jazz Pharmaceuticals' $4 Billion AbCellera Deal Ignites Next-Gen T-Cell Engager Race for Solid Tumors
Robert Ashworth · 14h ago
Sanofi Secures FDA Expansion for Type 1 Diabetes Drug Tzield, Boosting Market Access
Meera Krishnan · 15h ago
CinnaGen's Zandoriah®: First EU Authorization for Teriparatide Biosimilar in Osteoporosis Across 30 EEA States
Meera Krishnan · 15h ago
Germany Abandons Branded Pharmaceutical Price Reduction Plan Amid Industry Opposition
Catherine Morrow · 17h ago
Moderna Restructures Leadership for 2027-2028 Product Launches: Key Implications for Supply Chain and Regulatory Affairs
Robert Ashworth · 17h ago
Jazz Pharmaceuticals Forges Strategic Oncology Alliance with AbCellera for Next-Generation Multispecific Antibodies
Robert Ashworth · 17h ago
WHO Strengthens Global Clinical Trial Transparency and Good Practices: Implications for Pharma Supply Chains
Rohan Mehta · 18h ago
Strategic Imperative: Leveraging FDA Orange Book Data Files for Chemical and Life Sciences Market Intelligence
Priya Subramaniam · 18h ago
Health Canada's Drug Product Database: A Critical Resource for Market Intelligence and Regulatory Compliance
Priya Subramaniam · 18h ago
FDA Enhances Drug Master File Reviews Under GDUFA III: Strategic Implications for API Supply and Generic Market Access
Catherine Morrow · 18h ago
CDSCO Authorizes Oseltamivir Outlets: Clarifying India's Supply Channels for H1N1 Antivirals
Catherine Morrow · 18h ago
TG Therapeutics Halts Phase 1b Trial for Novel CD47/CD19 Bispecific TG-1801 in B-Cell Lymphoma and CLL
Catherine Morrow · 18h ago
Inhibrx Biosciences' Ozekibart BLA Acceptance Signals New Treatment Horizon for Chondrosarcoma
Catherine Morrow · 18h ago
FiberSense Secures CE Mark for CGM System: Strategic Entry into European Diabetes Management Market
Meera Krishnan · 19h ago
Vedana Therapeutics Secures $46M to Advance Anti-PACAP Migraine Therapies, Reshaping Treatment Landscape
Priya Subramaniam · 20h ago
Edgewise Therapeutics' EDG-7500 Phase 2 Data Shows Strong Efficacy in Hypertrophic Cardiomyopathy
Lakshmi Venkataraman · 21h ago
Altaris Acquires Simulations Plus for $375M: Reshaping Computational Drug Discovery Landscape
Robert Ashworth · 22h ago
Merck's $510M Protillion Deal Signals Major AI Shift in Biologics Discovery
Robert Ashworth · 23h ago
Eli Lilly's Strategic Acquisition of 4E Therapeutics Bolsters Non-Opioid Pain Pipeline with MNK Inhibitors
Robert Ashworth · 2d ago
Express Scripts, PCMA Challenge Tennessee's FAIR Rx Act: PBM Vertical Integration Under Threat
Ravi Chandrasekaran · 2d ago
Moderna's mFlusiva Flu Vaccine Faces Intense FDA Scrutiny Ahead of Pivotal Advisory Panel Vote
Meera Krishnan · 2d ago
Neumora Halts Navacaprant Depression Program After Phase 3 Failure: Market Repercussions
Arjun Sharma · 2d ago
Edgewise Therapeutics' EDG-7500 Phase 2 Data Signals Strong Competitive Entry in Hypertrophic Cardiomyopathy Market
Lakshmi Venkataraman · 2d ago
Novo Nordisk Accelerates Wegovy Launch in China Amidst Patent Expiry and Eli Lilly Rivalry
James Whitfield · 2d ago
GLP-1 Persistence Study Reveals Critical Discontinuation and Reinitiation Trends for Type 2 Diabetes Management
Lakshmi Venkataraman · 2d ago
Neumora's Navacaprant Phase 3 Failure Reshapes Major Depressive Disorder Pipeline and Kappa Opioid Receptor Strategy
Lakshmi Venkataraman · 2d ago
Request Terminal access
Get the morning brief and full intelligence feed delivered to your team.